Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03553706
Other study ID # KBC2052018
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 20, 2018
Est. completion date May 30, 2018

Study information

Verified date May 2018
Source University Hospital of Split
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Objective To access predictive values of the auxological parameters and indexes for risk of comorbid malformations in newborns with Down syndrome (DS)

Study design In this cohort retrospective study, 141 newborns with proven trisomy 21 born at the Department of Gynecology and Obstetrics of the University of Split Hospital (1990 to 2015) were included. The data were obtained from the medical histories of mothers, infants and the delivery protocol.

The objective was to access predictive values of the auxological parameters and indexes for risk of comorbid malformations in newborns with Down syndrome (DS)

Conclusion Higher CI were found in hyportrophic (SGA) newborns with DS and indicated their intrauterine growth restriction with brain sparing and increased further risk of severe psychomotor retardation. The SGA newborns have lower parameters and indexes of nutritive status and significantly differed from eutrophic and hypertrophic newborns. These SGA newborns with DS have increased developmental risks and that requires further diagnostic attention.


Description:

Use of anthropometric charts developed specifically for children with DS have a better expression of real growth restriction (small for gestation age/SGA, 9.9%) than the application of the percentile curve for typical children (SGA, 24.1%). These differences were also noted in the evaluation of other anthropometric measures. Cephalization index (CI) proved to be the only predictor from the considered auxological parameters and indexes with minimal predictive value in the prediction of heart defects type ASD II and VSD.

The presence of comorbid disorders in newborns with DS did not have a significant predictive role on growth indicators and nutritive status of the newborn, but we noted a strong association between preterm births and white matter injury (WMI).


Recruitment information / eligibility

Status Completed
Enrollment 141
Est. completion date May 30, 2018
Est. primary completion date May 30, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 1 Month
Eligibility Inclusion Criteria:

The study included newborns with proven trisomy 21 born at the Department of Gynecology and Obstetrics of the University of Split Hospital Center from 1990 to 2015

Exclusion Criteria:

- excluded newborns with proven trisomy 21 died at first week of life

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Croatia Asija Rota Ceprnja Split Dalmatia

Sponsors (1)

Lead Sponsor Collaborator
University Hospital of Split

Country where clinical trial is conducted

Croatia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Categorization of subjects according to norms of growth rates for typical children and children with Down syndrome Comparison of children with Down syndrome according to values of birth weight, birth length and head circumference classified by anthropometric charts for typical children and anthropometric charts for children with DS 7 days
Primary Testing the differences of auxological characteristic according to gestational age Comparison of auxological parameters and auxological indexes of premature and term babies with DS 7 days
Primary Auxological characteristics of SGA, AGA and LGA children with DS by norms for DS Comparison of auxological parameters and auxological indexes between hypotrophic (SGA), eutrophic (AGA) and hypertrophic (HGA) children with DS 7 days